Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Brune

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
MMW Fortschritte Der Medizin|November 9, 2007
[Lumiracoxib taken off the market in Australia. What does that mean for our patients? (interview by Dr. Judith Neumaier)]Kay Brune
MMW Fortschritte Der Medizin|March 11, 2008
[Randomized double blind study on traditional Chinese medicine. evidence remains questionable]Kay Brune
Current Opinion in Rheumatology|August 18, 2004
Pain and osteoarthritis: new drugs and mechanismsBurkhard Hinz, Kay Brune
Pharmazie in Unserer Zeit|April 30, 2002
[World-wide sales power of a drug group! The evolution of antipyretic analgesics]Kay Brune, Tobias Egger
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Herbal remedies for asthma treatment: between myth and realityIstvan Szelenyi, Kay Brune
Journal of Pain Research|March 12, 2015
New insights into the use of currently available non-steroidal anti-inflammatory drugsKay Brune, Paola Patrignani
Annals of the Rheumatic Diseases|November 1, 2011
Paracetamol and cyclooxygenase inhibition: is there a cause for concern?Burkhard Hinz, Kay Brune
Trends in Pharmacological Sciences|July 9, 2008
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacologyBurkhard Hinz, Kay Brune
Blood|July 20, 2002
Gene expression changes in blood after phlebotomy: implications for gene expression profilingAndreas Pahl, Kay Brune
Annals of the Rheumatic Diseases|August 2, 2011
Paracetamol, ibuprofen, or a combination of both drugs against knee pain: an excellent new randomised clinical trial answers old questions and suggests new therapeutic recommendationsKay Brune, Burkhard Hinz
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
MMW Fortschritte Der Medizin|November 9, 2007
[Lumiracoxib taken off the market in Australia. What does that mean for our patients? (interview by Dr. Judith Neumaier)]Kay Brune
MMW Fortschritte Der Medizin|March 11, 2008
[Randomized double blind study on traditional Chinese medicine. evidence remains questionable]Kay Brune
Current Opinion in Rheumatology|August 18, 2004
Pain and osteoarthritis: new drugs and mechanismsBurkhard Hinz, Kay Brune
Pharmazie in Unserer Zeit|April 30, 2002
[World-wide sales power of a drug group! The evolution of antipyretic analgesics]Kay Brune, Tobias Egger
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Herbal remedies for asthma treatment: between myth and realityIstvan Szelenyi, Kay Brune
Journal of Pain Research|March 12, 2015
New insights into the use of currently available non-steroidal anti-inflammatory drugsKay Brune, Paola Patrignani
Annals of the Rheumatic Diseases|November 1, 2011
Paracetamol and cyclooxygenase inhibition: is there a cause for concern?Burkhard Hinz, Kay Brune
Trends in Pharmacological Sciences|July 9, 2008
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacologyBurkhard Hinz, Kay Brune
Blood|July 20, 2002
Gene expression changes in blood after phlebotomy: implications for gene expression profilingAndreas Pahl, Kay Brune
Annals of the Rheumatic Diseases|August 2, 2011
Paracetamol, ibuprofen, or a combination of both drugs against knee pain: an excellent new randomised clinical trial answers old questions and suggests new therapeutic recommendationsKay Brune, Burkhard Hinz
Pageof 11